TY - JOUR
T1 - Defining Minimum Necessary Anticoagulation-Related Communication at Discharge
T2 - Consensus of the Care Transitions Task Force of the New York State Anticoagulation Coalition
AU - Triller, Darren
AU - Myrka, Anne
AU - Gassler, John
AU - Rudd, Kelly
AU - Meek, Patrick
AU - Kouides, Peter
AU - Burnett, Allison E.
AU - Spyropoulos, Alex C.
AU - Ansell, Jack
N1 - Funding Information:
The authors disclose receipt of the following financial support for the research, authorship, and/or publication of this article: The consensus statement was produced by the Care Transitions Task Force of the New York State Anticoagulation Coalition, which was assembled and supported by IPRO, the Centers for Medicare & Medicaid Services (CMS)designated Quality Improvement Network-Quality Improvement Organization (QIN-QIO) for New York State and lead for the Atlantic Quality Innovation Network (AQIN) under the 10th and 11th Statements of Work. The analyses on which this publication are based were performed under Contract Number HHSM-500-2014-QIN013I, funded by CMS, an agency of the US Department of Health and Human Services (HHS). The content of this publication does not necessarily reflect the views or policies of the HHS, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government. The authors assume full responsibility for the accuracy and completeness of the ideas presented. The authors acknowledge and appreciate the contributions of these additional anticoagulation experts to the Consensus Panel: MaryAnne Cronin, MS, PharmD, BCPS, Northwell Health, Great Neck, NY; Maria DeSancho, MD, Weill Cornell Medicine, New York City; Scott Kaatz, DO, MSc, Henry Ford Hospital, Detroit; Charles E. Mahan, PharmD, Presbyterian Hospital, Albuquerque, NM; Lynn B Oertel, NP, Massachusetts General Hospital, Boston; Carol Patrick, CNP, Northwell Health, Great Neck, NY; Elizabeth Phillips, PharmD, Upstate University Hospital, Syracuse, NY; Kathleen Reed, NP, Northwell Health, Great Neck, NY; Anne Rose, PharmD, University of Wisconsin Health, Madison; Gurdeep S. Sareen, PharmD, New York City; Karen M. Whalen, BS Pharm, BCPS, St. Joseph's Health, Syracuse, NY; Maura Wychowski, PharmD, BCPS, CACP, Rochester General Hospital, Rochester, NY. At the time that the task force completed the consensus process, Darren Triller was Senior Director at IPRO and Chair of the New York State Anticoagulation Coalition. Funding for his technical contributions to the authorship of the article was provided by IPRO. All authors report no conflicts of interest.
Funding Information:
The authors disclose receipt of the following financial support for the research, authorship, and/or publication of this article: The consensus statement was produced by the Care Transitions Task Force of the New York State Anticoagulation Coalition, which was assembled and supported by IPRO, the Centers for Medicare & Medicaid Services (CMS)designated Quality Improvement Network-Quality Improvement Organization (QIN-QIO) for New York State and lead for the Atlantic Quality Innovation Network (AQIN) under the 10th and 11th Statements of Work. The analyses on which this publication are based were performed under Contract Number HHSM-500-2014-QIN013I, funded by CMS, an agency of the US Department of Health and Human Services (HHS). The content of this publication does not necessarily reflect the views or policies of the HHS, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government. The authors assume full responsibility for the accuracy and completeness of the ideas presented.
Publisher Copyright:
© 2018 The Joint Commission
PY - 2018/11
Y1 - 2018/11
N2 - Background: Anticoagulated patients are particularly vulnerable to ADEs when they experience changes in medical acuity, pharmacotherapy, or care setting, and resources guiding care transitions are lacking. The New York State Anticoagulation Coalition convened a task force to develop a consensus list of requisite data elements (RDEs) that should accompany all anticoagulated patients undergoing care transitions. Methods: A multidisciplinary panel of 15 anticoagulation experts voluntarily completed an iterative Delphi process. Resources were disseminated and deliberated via remote technology, with consensus achieved via blinded electronic polling. Results: The panel reached consensus on a list of 15 RDEs for anticoagulation communication at discharge (the ACDC List). Consensus was rapidly achieved by the full panel on 13 elements, while 3 (2 of which were combined into 1 element) required multiple iterations and achieved consensus with votes from 8 available panelists. The elements encompassed a range of factors, including drug use and indications, previous exposure and duration of therapy, recent drug exposure and laboratory results and expectations for subsequent administration, therapy goals, patient education and comprehension, and expectations for clinical management. Twelve of the elements are applicable to any anticoagulant, and 3 are specific to warfarin. Conclusion: The ACDC List identifies specific pieces of clinical information that a panel of anticoagulant experts agree should be communicated to downstream providers for all anticoagulated patients undergoing care transitions. Additional study is needed to objectively evaluate the ability of existing care systems to communicate the elements and to assess possible relationships between communication of the elements and clinical outcomes.
AB - Background: Anticoagulated patients are particularly vulnerable to ADEs when they experience changes in medical acuity, pharmacotherapy, or care setting, and resources guiding care transitions are lacking. The New York State Anticoagulation Coalition convened a task force to develop a consensus list of requisite data elements (RDEs) that should accompany all anticoagulated patients undergoing care transitions. Methods: A multidisciplinary panel of 15 anticoagulation experts voluntarily completed an iterative Delphi process. Resources were disseminated and deliberated via remote technology, with consensus achieved via blinded electronic polling. Results: The panel reached consensus on a list of 15 RDEs for anticoagulation communication at discharge (the ACDC List). Consensus was rapidly achieved by the full panel on 13 elements, while 3 (2 of which were combined into 1 element) required multiple iterations and achieved consensus with votes from 8 available panelists. The elements encompassed a range of factors, including drug use and indications, previous exposure and duration of therapy, recent drug exposure and laboratory results and expectations for subsequent administration, therapy goals, patient education and comprehension, and expectations for clinical management. Twelve of the elements are applicable to any anticoagulant, and 3 are specific to warfarin. Conclusion: The ACDC List identifies specific pieces of clinical information that a panel of anticoagulant experts agree should be communicated to downstream providers for all anticoagulated patients undergoing care transitions. Additional study is needed to objectively evaluate the ability of existing care systems to communicate the elements and to assess possible relationships between communication of the elements and clinical outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85050303837&partnerID=8YFLogxK
U2 - 10.1016/j.jcjq.2018.04.015
DO - 10.1016/j.jcjq.2018.04.015
M3 - Article
C2 - 30064950
AN - SCOPUS:85050303837
SN - 1553-7250
VL - 44
SP - 630
EP - 640
JO - Joint Commission Journal on Quality and Patient Safety
JF - Joint Commission Journal on Quality and Patient Safety
IS - 11
ER -